Table 3. Biodegradable scaffolds.
Polymer assembly | Cell type seeded | Preconditioning scheme | Culture time | In vivo system | Explant histology | Patency | Ref. |
---|---|---|---|---|---|---|---|
Polyglycolide fibers reinforced with a Dacron® outer sleeve | – | – | – | Rabbit aorta | Endothelial- and smooth muscle-like cell infiltration | At least 9 months | [49] |
Poly(ether urethane urea) (Lycra) scaffold impregnated with PEG/PLA | – | – | – | Canine carotid arteries | Improvement of transmural tissue ingrowth and vascularization; thin, uniform intima and EC lining | At least 3 months | [158] |
PLGA fiber mesh compounded with collagen microsponge was frozen and lyophilized prior to glutaraldehyde crosslinking | – | – | – | Pulmonary trunks of beagle dogs | No intimal thickening; EC monolayer and parallel alignment of SMCs; reconstructed vessel wall with elastin and collagen fibers | At least 6 months | [159] |
Electrospun PCL | – | – | – | Rat abdominal aorta | Confluent endothelium at 12 weeks; neocapillary formation; thin neointima | At least 24 weeks | [160] |
Electrospun PLLA membrane consisting of nanofibers | Bone marrow MSCs | MSCs seeded onto membranes, then rolled into 0.7 mm mandrel | 3 days | Rat common carotid artery | Development of elastic lamina layer; no significant intimal hyperplasia; organized vascular cell infiltration | At least 60 days | [161] |
Nonwoven PGA mesh coated with poly 4-hydroxy-butyrate | Ovine vascular myofibroblasts and ECs | Sequential seeding and culture of myofibroblasts and ECs | 21 days | Main pulmonary artery in lambs | Stiffer tissue properties compared with native artery due to increased collagen content and no elastin production; no thrombus formation or calcification; appropriate EC and SMC layers were present | At least 100 weeks | [162] |
EC: Endothelial cell; MSC: Mesenchymal stem cell; PCL: Polycaprolactone; PEG: Polyethylene glycol; PGA: Polyglycolic acid; PLA: Polylactic acid; PLGA: Polylactide-coglycolide; PLLA: Poly-l-lactic acid